Bio-IT World January 7, 2025
By Bio-IT World Team

2024 was full of innovative ideas and achievements. We spoke with industry experts and leaders about what to anticipate in the new year. Artificial intelligence (AI) is expected to continue its stride, and, as we head into 2025, “life sciences is becoming the industry to watch for its application of generative AI (GenAI) and large language models (LLMs),” according to Aman Wasan of ArisGlobal.

It seems like the increasing development of AI/ML will lead to a greater focus on multimodal models, Christian Olsen of Dotmatics predicts, “Pharmaceutical and biotech companies are shifting from single-mode discovery toward a multimodal approach for research and development (R&D) in pursuit of new drug targets and therapies. Leading-edge players in drug...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
The Future of Cancer Drug Development: Advancements, Challenges, and the Transformative Role of AI
Fierce Biotech Fundraising Tracker '25: Alebund adds $75M; XyloCor raises $67M
J&J says its lung cancer drug combination keeps people alive longer
How GLP-1s Are Showing Up at CES 2025
Will AI revolutionize drug development? Researchers explain why it depends on how it's used

Share This Article